HMGI-C and HMGI(Y)immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes

Laboratory Investigation

Volumn 80, Issue 3, 2000, Pages 359-369

  Tallini, G ^a,h   Vanni, R ^b   Manfioletti, G ^c   Kazmierczak, B ^d   Faa, G ^b   Pauwels, P ^e   Bullerdiek, J ^d   Giancotti, V ^c   Van Den Berghe, H ^f   Dal Cin, P ^g  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

^d UNIVERSITY OF BREMEN   (Germany)

^e Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP PROTEIN; HIGH MOBILITY GROUP PROTEIN HMGI C; HIGH MOBILITY GROUP PROTEIN HMGI Y; UNCLASSIFIED DRUG;

AGED; ARTICLE; CELLULAR DISTRIBUTION; CHROMOSOMAL LOCALIZATION; CHROMOSOME 12P; CHROMOSOME 6P; CONTROLLED STUDY; HAMARTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; KARYOTYPING; LEIOMYOMA; LIPOMA; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 17144468766     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780040     Document Type: Article

References (48)

1. Ashar HR, Schoenberg Fejzo M, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, and Chada K (1995). Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82:57-65.
2. Bandiera A, Bonifacio D, Manfioletti G, Mantovani F, Rustighi A, Zanconati F, Fusco A, Di Bonito L, and Giancotti V (1998). Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res 58: 426-431.
3. Berlingieri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V, and Fusco A (1995). Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol 15:1545-1553.
4. Bussemakers MJG, van de Ven WJM, Debruyne FMJ, and Schalken JA (1991). Identification of high mobility group protein I (Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res 51:606-611.
5. Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F, Merciai BM, Fidanza V, Giancotti V, Santoro M, Simeone A, and Fusco A (1996). High level expression of the HMGI (Y) gene during embryonic development. Oncogene 13:2439-2446.
6. Chiappetta G, Bandiera A, Berlingieri MT, Visconti R, Manfioletti G, Battista S, Martinez-Tello FJ, Santoro M, Giancotti V, and Fusco A (1995). The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasms. Oncogene 10:1307-1314.
7. Chiappetta G, Tallini G, DeBiasio MC, Manfioletti G, Martinez-Tello FJ, Pentimalli F, de Nigris F, Mastro A, Botti G, Fedele M, Berger N, Santoro M, Giancotti V, Fusco A (1998). Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res 58:4193-4198.
8. Dal Cin P, Timmerman D, Van den Berghe I, Wanschura S, Kazmierczak B, Vergote I, Deprest J, Neven P, Moerman P, Bullerdiek J, and Van den Berghe H (1998a). Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen. Cancer Res 58:2278-2281.
9. Dal Cin P, Vanni R, Marras R, Moerman P, Kools P, Andria M, Valdes E, Deprest J, Van de Ven W, and Van den Berghe H (1995). Four cytogenetic subgroups can be identified in endometrial polyps. Cancer Res 55:1565-1568.
10. Dal Cin P, Wanschura S, Kazmierczak B, Tallini G, Dei Tos A, Bullerdiek J, Van den Berghe I, Moerman P, and Van den Berghe H (1998b). Amplification and expression of the HMGIC gene in a benign endometrial polyp. Genes, Chromosom, Cancer 22:95-99.
11. de Boer CJ, Schuuring E, Dreef E, Peters G, Bartek J, Kluin PM, and van Krieken JH (1995). Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 86:2715-2723.
12. de Boer CJ, van Krieken JH, Schuuring E, and Kluin PM (1997). Bcl-1/cyclin D1 in malignant lymphoma. Ann Oncol 8:109-117.
13. Fedele M, Bandiera A, Chiappetta G, Battista S, Viglietto G, Manfioletti G, Casamassimi A, Santoro M, Giancotti V, and Fusco A (1996). Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res 56:1896-1901.
14. Fletcher JA, Pinkus GS, Donavan K, Naeem R, Sugarbaker DJ, Mentzer S, Pinkus JL, and Longtine J (1992a). Clonal rearrangement of band 6p21 in the mesenchymal component of pulmonary chondroid hamartoma. Cancer Res 52:6224-6228.
15. Fletcher JA, Pinkus JL, Lage JM, Morton CC, and Pinkus GS (1992b). Clonal 6p21 rearrangement is restricted to the mesenchymal component of an endometrial polyp. Genes Chromosom Cancer 5:260-263.
16. Friedmann M, Holth LT, Zoghbi HY, and Reeves R (1993). Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res 21:4259-4267.
17. Gattas GJ, Quade BJ, Nowak RA, and Morton CC (1999). HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. Genes Chromosom Cancer 25:316-22.
18. Giancotti V, Buratti E, Perissin L, Zorzet S, Balmain A, Portella G, Fusco A, and Goodwin GH (1989). Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp Cell Res 184:538-545.
19. Giancotti V, Pani B, D'Andrea P, Berlingieri MT, Di Fiore PP, Fusco A, and Vecchio G (1987). Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with ras and v-mos oncogenes and by co-transfection with c-myc and polyoma middle T genes. EMBO J 6:1981-1987.
20. Hirning-Folz U, Wilda M, Rippe V, Bullerdiek J, and Hameister H (1998). The expression pattern of the HMGIC gene during development. Genes, Chromosom Cancer 23:350-357.
21. Kazmierczak B, Dal Cin P, Wanschura S, Bartnitzke S, Van den Berghe H, and Bullerdiek J (1998a). Cloning and molecular characterization of part of a new gene fused to HMGIC in mesenchymal tumors. Am J Pathol 152:431-435.
22. Kazmierczak B, Dal Cin P, Wanschura S, Borrmann L, Fusco A, Van den Berghe H, and Bullerdiek J (1998b). HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors. Genes, Chromosom Cancer 23:279-285.
23. Kazmierczak B, Hennig Y, Wanschura S, Rogalla P, Bartnitzke S, Van de Ven W, Bullerdiek J (1995a). Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene. Cancer Res 55:6038-6039.
24. Kazmierczak B, Meyer-Bolte K, Tran KH, Wöckel W, Breightman I, Rosigkeit J, Bartnitzke S, Bullerdiek J (1999). A high frequency of tumors with rearrangements of genes of the HMGI(Y) family in a series of 191 pulmonary chondroid hamartomas. Genes Chromosom Cancer 26:125-133.
25. Kazmierczak B, Pohnke Y, and Bullerdiek J (1996a). Fusion transcripts between the HMGI-C gene and RTVLH-related sequences in mesenchymal tumors without cytogenetic aberrations. Genomics 38:223-226.
26. Kazmierczak B, Rosigkeit J, Wanschura S, Meyer-Bolte K, Van de Ven WJM, Kayser K, Krieghoff B, Hastendiek H, Bartnitzke S, Bullerdiek J (19965). HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. Oncogene 12:515-521.
27. Kazmierczak B, Wanschura S, Meyer-Bolte K, Cavelitz J, Meister P, Bartnitzke S, and Van de Ven W (1995b). Cytogenetic and molecular analysis of an aggressive angiomyxoma. Am J Pathol 147:580-585.
28. Kazmierczak B, Wanschura S, Rommel B, Bartnitzke S, and Bullerdiek J (1996c). Ten pulmonary chondroid hamartomas with chromosome 6p21 breakpoints within the HMG-I(Y) gene or its immediate surroundings. J Natl Cancer Inst 88:1234.
29. Kievits T, Dauwerse JG, Wiegant J, Devilee P, Breuning MH, Cornelisse CJ, van Ommen G, and Pearson PL (1992). Rapid chromosomal localization of cosmids by using non-radioactive in situ hybridization. Cytogenet Cell Genet 53: 134-135.
30. Manfioletti G, Giancotti V, Bandiera A, Buratti E, Sautiere P, Cary P, Crane-Robinson C, Coles B, and Goodwin GH (1991). cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res 19:6793-6797.
31. Mitelman F (1998). Catalog of chromosomal aberration in cancer (6th ed)., New York: Wiley Liss.
32. Petit MMR, Mols R, Schoenmakers EFPM, Mandahl N, and Van De Ven WJM (1996). LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family. Genomics 36:118-129.
33. Rabbitts TH (1994). Chromosomal translocations in human cancer. Nature 372:143-149.
34. Ram TG, Reeves R, and Hosick HL (1993). Elevated high mobility group I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res 53:2655-2660.
35. Rogalla P, Drechsler K, Frey G, Hennig Y, Helmke B, Bonk U, and Bullerdiek J (1996). HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am J Pathol 149:775-779.
36. Rogalla P, Drechsler K, Kazmierczak B, Rippe V, Bonk U, and Bullerdiek J (1997). Expression of HMGI-C a member of the high mobility group protein family, in a subset of breast cancers: relationship to histologic grade. Mol Carcinogen 19:153-156.
37. Rommel B, Rogalla P, Jox A, Kalle CV, Kazmierczak B, Wolf J, and Bullerdiek J (1997). HMGI-C, a member of the high mobility group family of proteins is expressed in hematopoietic stem cells and leukemic cells. Leuk Lymphoma 26:603-607.
38. Schoenberg Fejzo M, Ashar HR, Krauter KS, Powell WL, Rein MS, Weremowicz S, Yoon S-Y, Kucherlapati RS, Chada K, and Morton CC (1996). Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas. Genes Chromosom Cancer 17:1-6.
39. Schoenmakers EFPM, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, and Van de Ven WJM (1995). Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nature Genet 10:436-444.
40. Staats B, Bonk U, Wanschura S, Hanisch P, Schoenmakers EFPM, Van de Ven WJM, Bartnitzke S, and Bullerdiek J (1996). A fibroadenoma with a t(4;12)(q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family. Breast Cancer Res Treat 38:299-308.
41. Tallini G, Dal Cin P, Rhoden KR, Chiappetta G, Manfioletti G, Giancotti V, Fusco A, Van den Berghe H, Sciot R (1997). Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors, Immunohistochemical reactivity correlates with karyotypic alterations. Am J Pathol 151:37-43.
42. Tamimi Y, van der Poel HG, Denyn M-M, Umbas R, Karthaus HFM, Debruyne FMJ, and Schalken JA (1993). Increased expression of high mobility group protein I (Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res 53:5512-5516.
43. Tkachenko A, Ashar HR, Meloni AM, Sandberg AA, and Chada KK (1997). Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis. Cancer Res 57:2276-2280.
44. Wanschura S, Dal Cin P, Kazmierczak B, Barnitze S, Van den Berghe H, and Bullerdiek J (1997). Hidden paracentric inversions of chromosome arm 12q affecting the HMGI-C gene. Genes Chromosom Cancer 18:322-323.
45. Wanschura S, Kazmierczak B, Pohnke Y, Meyer-Bolte K, Bartnitzke S, Van de Ven WJM, Bullerdiek J (1996). Transcriptional activation of HMGI-C in three pulmonary hamartomas each with a der(14) t(12;14) as the sole cytogenetic abnormality. Cancer Letters 102:17-21.
46. Wanschura S, Kazmierczak B, Schoenmakers EFPM, Meyen E, Bartnitzke S, Van de Ven WJM, Bullerdiek J, and Schloot W (1995). Regional fine mapping of the multiple aberration region involved in uterine leiomyomas, lipomas and pleomorphic adenomas of the salivary gland to 12q15. Genes Chromosom Cancer 14:68-70.
47. Williams AJ, Powell WL, Collins T, and Morton CC (1997). HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm. Am J Pathol 150:911-918.
48. Xiao S, Lux ML, Reeves R, Hudson TJ, and Fletcher JA (1997). HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma. Am J Pathol 150:901-910.